Lifestyle Factors and Sexual Health Solutions

Other > the pink pill for women


The Pink Pill: Sex, Drugs & Who Has Control is streaming on Paramount+ in Canada and the U.S.

Benefit Description Evidence Level Common Side Effects
Mood Stabilization Helps reduce anxiety and improve mood Moderate Headaches, nausea
Increased Libido Boosts sexual desire Anecdotal, some studies Fatigue, dizziness
Better Sleep Promotes better quality sleep Consistent reports Drowsiness, dry mouth
Energy Boost Provides a natural increase in daytime alertness Limited clinical data Jitters, insomnia

as of March 6, 2026.

i don’t have sexual thoughts anymore

Lee highlights that FDA choices and approvals are not just regulatory decisions, but that they also shape who can get care and how easily. “If you’re a cisgender, white male, health care in the United States is pretty darn good, and your health care experience can be a uniquely personal one,” she said. In other words, women and minority groups often don’t have a similar, positive experience. “FDA decisions are not just scientific determinations, but structural choices that shape access, risk, and who benefits from innovation,” said Lee. The FDA declined approval for Addyi in 2010 and 2013, with some critics referring to the treatment as “an ineffective drug for a nonexistent problem.” However, data from the University of Colorado Anschutz Department of Obstetrics and Gynecology shows that 10% of women across all age groups suffer from HSDD, which can “cause significant levels of personal distress.” To put it into perspective, HSDD is just as common as autoimmune disorders like rheumatoid arthritis, and in the U.S.

How does Addyi work (mechanism of action)?

alone there are nearly a million patients taking oral medication to treat their autoimmune condition. Though HSDD is not a threat to physical wellbeing, both conditions can have significant impact on a person’s life. Like most medications, Addyi doesn’t work for everyone, but its availability gives women struggling with HSDD an option that otherwise doesn’t exist. Still, early research didn’t quite satisfy the FDA. “When the data first went up for review in 2010, the FDA did not feel that there was enough data to support Addyi’s effectiveness,” said Lee.

What are the most common side effects of Addyi?

The drug was originally tested in a clinical trial with over 2,000 premenopausal women either taking Addyi or a placebo pill. Participants taking Addyi were 10% more likely to report an increase in satisfying sexual events. A more recent study found that about half of women taking Addyi reported benefit to their sex life. Advocates for women’s health criticized the FDA’s early rejections and claimed gender bias, especially because Viagra was approved under an expedited priority review process, taking less than a year to achieve approval. Though the purposes of Addyi and Viagra are similar, Addyi corrects chemical imbalances of certain neurotransmitters in the brain that are responsible for sexual desire or excitement, which makes the drug approval process more complex. Much research needs to be done on female sex performance, given that reasons for low sex drive in different women, we need to have more than one “pink pill” for women like guys have little blue pill.

Product Dosage Quantity + Bonus Price
Levitra Generic40mg30 + 2 Pills93.58€ 89.12€
Kamagra Soft Tabs100 mg272 + 12 Pills593.42€ 565.16€
Kamagra Soft Tabs100 mg60 + 4 Pills180.59€ 171.99€
Cialis Generic40mg60 + 6 Pills130.98€ 124.74€
Viagra Generic50mg60 + 4 Pills83.93€ 79.93€
Cialis Generic2.5mg180 + 10 Pills154.86€ 147.49€
Kamagra Oral Jelly100 mg30 + 5 Sachets136.20€ 129.71€
Kamagra100mg120 + 6 Pills330.74€ 314.99€
Viagra Generic25mg20 Pills37.74€ 35.94€
Cialis Generic10mg20 Pills48.23€ 45.93€
Cialis Generic2.5mg10 Pills28.51€ 27.15€
Cialis Professional20mg30 Pills104.57€ 99.59€
Priligy Generic Dapoxetine60mg120 + 10 Pills341.26€ 325.01€
Cialis Generic10mg180 + 8 Pills236.88€ 225.60€
Kamagra Gold50 mg32 Pills103.06€ 98.15€
Kamagra Polo100 mg120 + 6 Pills327.15€ 311.57€
Super Kamagra160 mg4 Pills41.99€ 39.99€

Addyi was the first approved medicine to improve libido in women.

  • Pink pills are part of a broader trend towards female-centered wellness.
  • They can potentially enhance intimacy, confidence, and overall satisfaction.
  • Unregulated products pose risks of contamination or inappropriate ingredients.
  • Always verify product credentials and manufacturer reputation before purchase.

Some women, once libido returns think their arousal is improved, but the medication works on brain centers of desires and shouldn’t really change your physical performance.

Controversy Over the Little Pink Pill

Brady would be happy to review whether it is a viable option for you. It is important, as with any medication to weigh the benefits against potential side effects and alternative treatments. Specifically, it is important to avoid alcoholic beverages if a patient chooses to take Flibanserin. Which leads us to the alternative treatments… Many women aren’t aware of the various treatment options for female sexual health. For example, hormone replacement therapy has been shown to significantly improve a woman’s libido.

Liver impairment

For our patients who are experiencing physical issues such as painful intercourse due to vaginal dryness, MonaLisa Touch™ therapy has been life-changing (we have a 100% satisfaction rate among our patients!). Regardless of the reasons for a woman’s lack of sexual motivation, we can help get to the root of the problem and get our patients started on the appropriate treatment. A healthy sex life is an important part of our emotional and overall wellness, and we can get you back into the groove! While sexual dysfunction affects both men and women, men have 26 delayed ejaculation pills FDA-approved treatments to choose from. A new documentary explains that it’s in part because the FDA drug approval process determines which sexual health options are available, and how restrictions or labeling decisions can limit access for certain groups.

Common side effects

“When you look at women — premenopausal, postmenopausal, transgender individuals — the conversation of what is available to you is not dictated by you,” explains Johns Hopkins Carey Business School Law and Ethics Professor Stacey Lee in The Pink Pill: Sex, Drugs & Who Has Control. Addyi, or flibanserin, treats Hypoactive Sexual Desire Disorder, a common condition defined by lack of sexual desire in women. It has yet to achieve the same kind of widespread use or acceptance as men’s Viagra, which is used by millions of patients annually since its 1998 debut. The Pink Pill recounts the journey of Sprout Pharmaceuticals Founder and CEO Cindy Eckert, the entrepreneur whose company developed and brought Addyi to market, as she set out to expand access for sexual health treatments for women. Eckert’s path in developing Addyi for patient use was more of a struggle than it should’ve been, according to the documentary, which calls out the inequalities in availability of sexual health treatment between men and women. If your sex isn’t fun, you won’t have libido so we feel it’s important to address the subject of vaginal health.

  • Pink pills are sometimes used to address sexual dysfunction in women.
  • They are marketed as natural or holistic remedies, depending on ingredients.
  • Medical approval varies; some are unregulated, over-the-counter supplements.
  • Users should check for FDA approval or medical supervision before use.

There are many new therapies for female sexual disorders and vaginal disorders which have been FDA Cleared, including MonaLisa Touch CO2 Laser, ThermiVa Radiofrequency treatment, or Emsella chair on sexuality setting.

What does finally receiving FDA approval for Addyi in post-menopausal women mean for women’s health?

“Erectile dysfunction was seen as an unmet physical ailment,” said Lee. Because of that, Viagra was evaluated as treatment to address a physical need. HSDD was not considered an unmet physical ailment in the eyes of the FDA but rather an unmet psychological ailment, which “immediately triggers a higher standard of review and additional safety measures,” Lee adds. While the drugs had to be evaluated differently, supporters of Addyi claimed that stigma and overly cautious FDA warnings deterred patient use even after it was approved. For example, doctors and pharmacists had to take a test, known as a Risk Evaluation and Mitigation Strategy assessment, to prescribe and administer Addyi.

Who should not use Addyi?

The assessment included an online slide presentation followed by a comprehension test that proved the medical professionals knew and understood the drug’s risks of potential low blood pressure and fainting when combined with alcohol. Even further, patients had to sign a paper vowing not to drink while on the medication even though Cialis--another medication used to treat erectile dysfunction in men--creates similar interactions with alcohol but comes with no more than an advisement to moderate alcohol use. At the time of approval, the FDA argued that Addyi’s interaction with alcohol hadn’t yet been adequately studied. In 2019 and after additional research was conducted, the FDA modified its original alcohol warning for Addyi and removed the test requirement for doctors and pharmacists. In December of super tadapox 100mg 2025, the FDA approved the drug for postmenopausal women, expanding access to more patients.

How should I store Addyi?

Advocates say a drug to treat women’s sexual dysfunction is a start to addressing health inequity. Lee adds that recent bigger picture events, though, like the overturn of Roe v. Wade and rollbacks on birth control access, have changed what health care looks like for women today. The approval and acceptance of Addyi is part of a much larger and ongoing conversation about women’s health and regulatory policy currently. “The past five to 10 years really calls into question where the state of women’s health is going,” Lee said. The first medical therapy approved for pain with intercourse in menopausal women is Osphena. It is an intriguing medication as it has bone health benefits against osteopenia, and decreases risk of breast cancer. Testosterone use for women can be important for strength, moods, fatigue, as well as for sex enhancement, has been tested in many forms, some of which are still in development stages and some look more promising than others, including, testosterone patches, gels, implants, and intranasal (male intranasal is approved), Tefina still in studies, and it can be used systemically or topically, depending on the condition you want to treat.

Why the FDA rejected Addyi twice

HealthyWomen: What can we expect to see next from The Pinkubator? Cindy Eckert: One of our companies just got clearance on a device that will revolutionize the epidural. It’s a mapping device for the spine that will guide you to exactly the right place the first time. It will change the patient experience and frankly change the cost of healthcare. HealthyWomen: What’s your advice for the next innovator or person who may be looking to start a new career later in life?

Related support groups

About the Change to the Female Libido Pill Warning - HealthyWomen › Flibanserin: Will It Ever Become the Female Viagra? Move over, little blue pill, we ladies now have our own version of – the little pink pill. For decades, we’ve been inundated (sometimes, even comically) with commercials and information about male sexual function and sexual health. While this is all well and good, very little attention was paid to the female counterpart to sexual well-being and the fact that women sometimes need a little help too. Whether it’s simply a low sex drive, experienced by roughly 33% of women, or something that manifests physically like painful intercourse, affecting a whopping 75% of women during their lifetime, female sexual dysfunction is an issue that is finally getting the attention it deserves.

IN CLINICAL TRIALS1, WOMEN ON ADDYI EXPERIENCED:

So what does this little pink pill (referred to as “female viagra” and called Flibanserin) do? Because a woman’s libido relies on a complexity of factors such as emotional, environmental, and physical health, the drug is thought to be beneficial because it alters dopamine and serotonin levels in the brain. In studies, the female participants reported an increase in the number of sexually satisfying events each month, which is a promising statistic. Flibanserin was approved by the FDA in August 2015 and will be available to patients in October 2015. Dr.